This content is from: Patents

UK Supreme Court wrestles with plausibility and the pregabalin patent

The UK Supreme Court last week heard argument in Warner Lambert v Generics. Pfizer argued that plausibility should be an "evidential tool" not a "threshold test", while Actavis warned against the danger of over-broad speculative claims and "armchair patenting”

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related